The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry
- PMID: 31190480
- PMCID: PMC6813154
- DOI: 10.4070/kcj.2019.0074
The Current Status of Intervention for Intermediate Coronary Stenosis in the Korean Percutaneous Coronary Intervention (K-PCI) Registry
Abstract
Background and objectives: Intermediate coronary lesion that can be under- or over-estimated by visual estimation frequently results in stenting of functionally nonsignificant lesions or deferral of percutaneous coronary intervention (PCI) of significant lesions inappropriately. We evaluated current status of PCI for intermediate lesions from a standardized database in Korea.
Methods: We analyzed the Korean percutaneous coronary intervention (K-PCI) registry data which collected a standardized PCI database of the participating hospitals throughout the country from January 1, 2014, through December 31, 2014. Intermediate lesion was defined as a luminal narrowing between 50% and 70% by visual estimation and then compared whether the invasive physiologic or imaging study was performed or not.
Results: Physiology-guided PCI for intermediate lesions was performed in 16.8% for left anterior descending artery (LAD), 9.8% for left circumflex artery (LCX), 13.2% for right coronary artery (RCA). PCI was more frequently performed using intravascular ultrasound (IVUS) than using fractional flow reserve (FFR) for coronary artery segments (27.7% vs. 13.9% for LAD, 32.9% vs. 8.1% for LCX, and 33.8% vs. 10.8% for RCA). In accordance with or without FFR, PCI for intermediate lesions was more frequently performed in the hospitals with available FFR device than without FFR, especially in left main artery (LM), proximal LAD lesion (40.9% vs. 5.9% for LM, 24.6% vs 7.6% for proximal LAD).
Conclusions: These data provide the current PCI practice pattern with the use of FFR and IVUS in intermediate lesion. More common use of FFR for intermediate lesion should be encouraged.
Keywords: Coronary artery disease; Fractional flow reserve, myocardial; Percutaneous coronary intervention.
Copyright © 2019. The Korean Society of Cardiology.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures



Similar articles
-
Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.JACC Cardiovasc Interv. 2010 Aug;3(8):812-7. doi: 10.1016/j.jcin.2010.04.016. JACC Cardiovasc Interv. 2010. PMID: 20723852
-
Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.Kardiol Pol. 2004 Apr;60(4):311-19; discussion 320-1. Kardiol Pol. 2004. PMID: 15226780 English, Polish.
-
Comparison of Fractional FLow Reserve And Intravascular ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with InteRmediate Stenosis (FLAVOUR): Rationale and design of a randomized clinical trial.Am Heart J. 2018 May;199:7-12. doi: 10.1016/j.ahj.2017.11.001. Epub 2017 Nov 6. Am Heart J. 2018. PMID: 29754669 Clinical Trial.
-
Fractional flow reserve versus angiography guided percutaneous coronary intervention: An updated systematic review.Catheter Cardiovasc Interv. 2018 Jul;92(1):18-27. doi: 10.1002/ccd.27302. Epub 2017 Oct 5. Catheter Cardiovasc Interv. 2018. PMID: 28980386
-
Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies.Int J Cardiol. 2018 Nov 15;271:42-48. doi: 10.1016/j.ijcard.2018.04.032. Int J Cardiol. 2018. PMID: 30223378
Cited by
-
Percutaneous coronary intervention in side branch coronary arteries: Insights from the Japanese nationwide registry.Int J Cardiol Heart Vasc. 2021 Aug 18;36:100856. doi: 10.1016/j.ijcha.2021.100856. eCollection 2021 Oct. Int J Cardiol Heart Vasc. 2021. PMID: 34430704 Free PMC article.
-
Diastolic Hyperemia-Free Ratio in Patients With Coronary Artery Disease: A Prospective Observational Study.Korean Circ J. 2025 Jul;55(7):600-610. doi: 10.4070/kcj.2024.0351. Epub 2025 Feb 17. Korean Circ J. 2025. PMID: 40206008 Free PMC article.
-
Impact of Arterial Remodeling of Intermediate Coronary Lesions on Long-Term Clinical Outcomes in Patients with Stable Coronary Artery Disease: An Intravascular Ultrasound Study.J Interv Cardiol. 2021 Jun 11;2021:9915759. doi: 10.1155/2021/9915759. eCollection 2021. J Interv Cardiol. 2021. PMID: 34220369 Free PMC article.
-
Reduction of In-Stent Restenosis and Inflammation with One Stent: New Concept of Sirolimus and Ascorbic Acid-Eluting Coronary Stent.Korean Circ J. 2021 Dec;51(12):1015-1016. doi: 10.4070/kcj.2021.0336. Korean Circ J. 2021. PMID: 34854581 Free PMC article. No abstract available.
-
Association of quantitative flow ratio-derived microcirculatory indices with anatomical-functional discordance in intermediate coronary lesions.Int J Cardiovasc Imaging. 2021 Oct;37(10):2803-2813. doi: 10.1007/s10554-021-02292-2. Epub 2021 May 31. Int J Cardiovasc Imaging. 2021. PMID: 34059977
References
-
- Park SJ, Kang SJ, Ahn JM, et al. Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv. 2012;5:1029–1036. - PubMed
-
- Trask N, Califf RM, Conley MJ, et al. Accuracy and interobserver variability of coronary cineangiography: a comparison with postmortem evaluation. J Am Coll Cardiol. 1984;3:1145–1154. - PubMed
-
- Katritsis D, Webb-Peploe M. Limitations of coronary angiography: an underestimated problem? Clin Cardiol. 1991;14:20–24. - PubMed
-
- Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2017;69:2212–2241. - PubMed
-
- Authors/Task Force members. Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J. 2014;35:2541–2619. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous